Alpha/beta-tubulin-N-acetyltransferase 9 (NAT9)

Homo sapiens — UniProt Q9BTE0

Gene: NAT9Homo sapiensSwissProt reviewed

About Alpha/beta-tubulin-N-acetyltransferase 9

Alpha/beta-tubulin-N-acetyltransferase 9 (NAT9) is a protein from Homo sapiens identified by UniProt accession Q9BTE0, 207 residues long. MolForge cross-references it against 0 known binders and 25 disease associations.

Target properties

Protein nameAlpha/beta-tubulin-N-acetyltransferase 9
UniProt accessionQ9BTE0
GeneNAT9
OrganismHomo sapiens
Length207 residues
Molecular weight—
EC numbers—
Target classUNCLASSIFIED
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (25)

Diseases linked to this target (Open Targets).

  • monocyte count · score 0.20
  • Red cell distribution width · score 0.19
  • monocyte percentage of leukocytes · score 0.19
  • basophil count · score 0.17
  • serum gamma-glutamyl transferase measurement · score 0.15
  • myeloid white cell count · score 0.05
  • neutrophil count · score 0.05
  • leukocyte count · score 0.04
  • lymphocyte percentage of leukocytes · score 0.02
  • psoriasis · score 0.01

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q9BTE0-F1alphafoldPREDICTED92.13—

Amino-acid sequence (207 residues)

MRLNQNTLLL GKKVVLVPYT SEHVPSRYHE WMKSEELQRL TASEPLTLEQ EYAMQCSWQE DADKCTFIVL DAEKWQAQPG ATEESCMVGD VNLFLTDLED LTLGEIEVMI AEPSCRGKGL GTEAVLAMLS YGVTTLGLTK FEAKIGQGNE PSIRMFQKLH FEQVATSSVF QEVTLRLTVS ESEHQWLLEQ TSHVEEKPYR DGSAEPC

Explore Alpha/beta-tubulin-N-acetyltransferase 9 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ9BTE0
GeneNAT9
OrganismHomo sapiens
Length207
Binders0
Diseases25
View on UniProt